HORIZON THERAPEUTICS PLC - COMMON STOCK-FO (HZNP)

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class
Equity / COMMON STOCK-FO
Total 13F shares
201,445,638
Share change
+3,400,329
Total reported value
$18,856,722,038
Put/Call ratio
38%
Price per share
$93.64
Number of holders
524
Value change
+$313,258,553
Number of buys
284
Number of sells
210

Institutional Holders of HORIZON THERAPEUTICS PLC - COMMON STOCK-FO (HZNP) as of Q2 2021

As of 30 Jun 2021, HORIZON THERAPEUTICS PLC - COMMON STOCK-FO (HZNP) was held by 524 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 201,445,638 shares. The largest 10 holders included VANGUARD GROUP INC, FMR LLC, BlackRock Inc., Avoro Capital Advisors LLC, PAULSON & CO. INC., JPMORGAN CHASE & CO, JANUS HENDERSON GROUP PLC, STATE STREET CORP, Nuveen Asset Management, LLC, and WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC. This page lists 524 institutional shareholders reporting positions in this security for the Q2 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.